Top Health-care stocks:
Health-care shares were mainly higher in pre-market trade on Wednesday.
In health-care stocks news, Marinus Pharmaceuticals ( MRNS ), which focuses on the development of treatments for epilepsy and neuropsychiatric disorders, said it has completed patient recruitment for the Phase 3 clinical trial of ganaxolone, a CNS-selective GABAA modulator, in adults with drug-resistant focal onset seizures.
Shares in the company were unchanged at $6.12 pre-bell. This is within the lower band of the stock's 52 week trading range between $4.52 and $20.72.
Biogen ( BIIB ), a global biopharmaceutical company, is collaborating with Arsia Therapeutics in the development of subcutaneous injection versions of the intravenous treatment for hemophilia.
The company was also inactive pre-bell at $289.11. This is within the lower band of the stock's 52 week trading range between $254 and $480.18.
And biopharmaceutical company Alkermes ( ALKS ) reported Wednesday new developments and milestones related to its proprietary product and late-stage pipeline portfolio of medicines for the treatment of central nervous system ( CNS ) diseases.
Shares were flat at $72.74 pre-bell. This is within the upper band of the stock's 52 week trading range between $53.01 and $75.99.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.